Protara Therapeutics, Inc. SEC filings TARA
Protara Therapeutics, Inc. has 809 filings in SEC EDGAR's recent list, going back to Apr 14, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| S-8 | Employee stock plan registration | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 7, 2026 | — |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 29, 2026 | Jun 26, 2026 |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 424B5 | Prospectus supplement | May 28, 2026 | — |
| EFFECT | Filing | May 22, 2026 | — |
| CORRESP | Letter to the SEC | May 20, 2026 | — |
| UPLOAD | Letter from the SEC | May 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| S-3 | Shelf registration | May 14, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 12, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 27, 2026 | — |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| 144 | Notice of proposed sale | Apr 23, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Apr 17, 2026 |
| 4 | Insider transaction | Apr 9, 2026 | Apr 8, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Apr 1, 2026 |
| 144 | Notice of proposed sale | Apr 1, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| 144 | Notice of proposed sale | Mar 6, 2026 | — |
| 424B7 | Prospectus supplement | Mar 6, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| 144 | Notice of proposed sale | Mar 4, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| 144 | Notice of proposed sale | Feb 25, 2026 | — |
| 144 | Notice of proposed sale | Feb 24, 2026 | — |
| 144 | Notice of proposed sale | Feb 24, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 24, 2026 | Feb 23, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| 424B7 | Prospectus supplement | Feb 2, 2026 | — |
| 4 | Insider transaction | Jan 27, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 27, 2026 | Jan 26, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 21, 2026 | — |
| 8-K |
Current report
Other events
|
Dec 15, 2025 | Dec 15, 2025 |
| 424B7 | Prospectus supplement | Dec 9, 2025 | — |
| 8-K |
Current report
Material agreement
|
Dec 8, 2025 | Dec 4, 2025 |
| 424B5 | Prospectus supplement | Dec 5, 2025 | — |
| 424B5 | Prospectus supplement | Dec 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 19, 2025 | Nov 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| S-8 | Employee stock plan registration | Aug 11, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jul 7, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 4, 2025 | Jun 2, 2025 |
| 3 | Initial insider ownership | Jun 4, 2025 | Jun 2, 2025 |
| 4/A | Primary document | May 19, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 28, 2025 | — |
| 424B7 | Prospectus supplement | Apr 28, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 28, 2025 | Apr 26, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Apr 17, 2025 | Apr 15, 2025 |
| 3 | Initial insider ownership | Apr 17, 2025 | Apr 15, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4/A | Primary document | Mar 28, 2025 | Jan 24, 2025 |
| 4/A | Primary document | Mar 28, 2025 | Jan 24, 2025 |
| 4/A | Primary document | Mar 28, 2025 | Jan 24, 2025 |
| 4/A | Primary document | Mar 28, 2025 | Jan 24, 2025 |
| 144 | Notice of proposed sale | Mar 26, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 7, 2025 | — |
| S-8 | Employee stock plan registration | Mar 5, 2025 | — |
| 10-K | Annual report | Mar 5, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2025 | Mar 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| SC 13G | Ownership over 5% (passive) | Dec 17, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 11, 2024 | Dec 9, 2024 |
| 424B5 | Prospectus supplement | Dec 11, 2024 | — |
| 424B5 | Prospectus supplement | Dec 9, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2024 | Dec 5, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 18, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Sep 12, 2024 | Sep 11, 2024 |
| 4 | Insider transaction | Sep 10, 2024 | Sep 9, 2024 |
| 4 | Insider transaction | Aug 30, 2024 | Aug 28, 2024 |
| S-8 | Employee stock plan registration | Aug 6, 2024 | — |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 4 | Insider transaction | Jul 18, 2024 | Jul 16, 2024 |
| 4 | Insider transaction | Jul 11, 2024 | Jul 9, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jun 28, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 30, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 17, 2024 | May 17, 2024 |
| 4 | Insider transaction | May 10, 2024 | May 9, 2024 |
| EFFECT | Filing | May 9, 2024 | — |
| 424B3 | Prospectus | May 9, 2024 | — |
| CORRESP | Letter to the SEC | May 7, 2024 | — |
| UPLOAD | Letter from the SEC | May 7, 2024 | — |
| S-3 | Shelf registration | May 2, 2024 | — |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Apr 25, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Apr 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Apr 9, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Apr 5, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2024 | Mar 18, 2024 |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 4 | Insider transaction | Jan 23, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 23, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 23, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 23, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 23, 2024 | Jan 19, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 12, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 5, 2024 | Jan 3, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- TARA (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1359931
- Former names
- Protara Therapeutics, Inc. (until Aug 13, 2026); ArTara Therapeutics, Inc. (until Apr 23, 2020); PROTEON THERAPEUTICS INC (until Dec 31, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.